quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:21:32·45d
SECFiling
Abbott Laboratories logo

Abbott Laboratories filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

ABT· Abbott Laboratories
Health Care
Original source

Companies

  • ABT
    Abbott Laboratories
    Health Care

Recent analyst ratings

  • Apr 22UpdateDaiwa Securities$92.00
  • Oct 10UpdateThe Benchmark Company$145.00
  • Jul 18UpdateJefferies$145.00
  • Jun 16UpdateLeerink Partners$143.00
  • Oct 8UpdateOppenheimer$130.00
  • Sep 19UpdatePiper Sandler$131.00

Related

  • ANALYST1d
    Abbott Labs downgraded by Daiwa Securities with a new price target
  • SEC6d
    Abbott Laboratories filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR6d
    New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
  • SEC7d
    Abbott Laboratories filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR7d
    Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences
  • PR14d
    New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health
  • INSIDER21d
    SEC Form 4 filed by Stratton John G
  • INSIDER21d
    SEC Form 4 filed by Roman Michael F
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022